Bruce & Co., Inc. — 13F Holdings & Portfolio

CIK 1358331 · latest 13F-HR filed 2026-08-14

Bruce & Co., Inc. manages $369.5M in 13F-reported U.S. long-equity assets across 41 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are ABBV (8.24%), ALL (7.89%), AER (7.30%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 21, and trimmed 13.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
20 N. WACKER DRIVE
SUITE 2414
CHICAGO, IL 60606
Phone
(312) 236-9160
Filing Manager
Bruce & Co., Inc.
CHICAGO, IL
Signatory
R. Jeffrey Bruce
President
Loading holdings…
AUM

$369.5M

Long-equity book

Holdings

41

Distinct positions

Period

2026-06-30

Filed 2026-08-14

Q/Q Activity

+0 / −0 / ↑21 / ↓13

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • Vicor$7.8M +74.2%
  • Beta Bionics$4.9M +89.0%
  • Uhaul B$3.9M +19.2%
  • Abbvie$3.8M +14.3%
  • Allstate$3.5M +13.7%
Show all 21

Top Trims

  • AT & T-$4.4M -29.3%
  • Nextera Energy-$2.1M -7.4%
  • Lyondellbasell-$1.7M -34.6%
  • Abbott-$1.5M -12.8%
  • Newmont-$1.5M -13.7%
Show all 13

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Abbvie ABBV 00287Y109 $30.4M 8.24% 121,000 SH
2 Allstate ALL 020002101 $29.1M 7.89% 122,500 SH
3 AerCap Holdings AER N00985106 $27.0M 7.30% 185,000 SH
4 Nextera Energy NEE 302571104 $25.8M 6.99% 294,300 SH
5 Merck MRK 589331107 $24.5M 6.64% 190,800 SH
6 Uhaul B UHAL.B 023586506 $24.1M 6.51% 417,000 SH
7 Duke Energy DUK 26441C204 $18.3M 4.96% 144,816 SH
8 Vicor VICR 925815102 $18.2M 4.93% 48,000 SH
9 XCEL Energy XEL 98389B100 $14.7M 3.97% 182,500 SH
10 CMS Energy CMS 125896100 $11.7M 3.17% 153,000 SH
11 AT & T T 00206R102 $10.7M 2.90% 518,000 SH
12 Apple AAPL 037833100 $10.7M 2.89% 36,900 SH
13 Beta Bionics BBNX 08659B102 $10.4M 2.82% 665,700 SH
14 Insteel IIIN 45774W108 $10.4M 2.81% 343,423 SH
15 Abbott ABT 002824100 $10.2M 2.76% 112,300 SH
16 Newmont NEM 651639106 $9.3M 2.53% 100,000 SH
17 Avista AVA 05379B107 $8.2M 2.21% 200,000 SH
18 Archer Daniels ADM 039483102 $7.6M 2.07% 100,000 SH
19 Bunge BG H11356104 $7.5M 2.02% 70,000 SH
20 Supernus SUPN 868459108 $7.0M 1.89% 150,000 SH
21 Pfizer PFE 717081103 $6.5M 1.75% 268,200 SH
22 Darling Ingredients DAR 237266101 $5.7M 1.55% 105,000 SH
23 Kodiak Sciences KOD 50015M109 $5.6M 1.53% 145,000 SH
24 Chemours CC 163851108 $5.1M 1.39% 250,000 SH
25 Uhaul UHAL 023586100 $4.8M 1.29% 72,600 SH
26 Lyondellbasell LYB N53745100 $3.2M 0.85% 60,000 SH
27 Personalis PSNL 71535D106 $3.1M 0.84% 233,000 SH
28 Fate Theraputics FATE 31189P102 $2.7M 0.72% 989,188 SH
29 Eli Lilly LLY 532457108 $2.4M 0.65% 2,000 SH
30 RLI RLI 749607107 $2.4M 0.64% 40,000 SH
31 Apogee APOG 037598109 $2.3M 0.62% 50,000 SH
32 FocalTherics FOCL 268311107 $2.3M 0.61% 438,652 SH
33 XM Sirius SIRI 82968B103 $1.6M 0.45% 55,784 SH
34 Venture Global VG 92333F101 $1.1M 0.30% 100,000 SH
35 Ashland ASH 044209104 $988.4K 0.27% 15,000 SH
36 Viatris VTRS 92556V106 $916.2K 0.25% 57,696 SH
37 Mannkind MNKD 56400P706 $831.0K 0.22% 195,073 SH
38 Bausch Health BHC 91911K102 $611.3K 0.17% 124,000 SH
39 908 Devices MASS 65443P102 $594.1K 0.16% 68,286 SH
40 WEC Energy WEC 92939U106 $460.7K 0.12% 3,945 SH
41 Caribou Biosciences CRBU 142038108 $440.0K 0.12% 250,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $369.5M 41 0001104659-26-096709
2026-03-31 2026-05-14 $349.7M 41 0001104659-26-061024
2025-12-31 2026-02-13 $322.5M 39 0001104659-26-015254
2025-09-30 2025-11-13 $322.9M 39 0001104659-25-111225